Research Article

Angiopoietin-2 Levels as Predictors of Outcome in Mechanically Ventilated Patients with Acute Respiratory Distress Syndrome

Table 1

Baseline demographic and clinical characteristics for survivors and nonsurvivors.

Survivors ()Nonsurvivors () value

Male gender (n, %)15 (60%)18 (64.3)0.783
Age (years, mean ± SD)63.6 ± 14.164.6 ± 16.80.822
APACHE II score (mean ± SD)20.7 ± 5.421.5 ± 6.60.625
SOFA score (mean ± SD)7.84 ± 3.709.07 ± 3.190.200
Lung injury score (mean ± SD)1.90 ± 0.462.48 ± 0.58<0.0001
Lung injury score > 2.25 (n, %)5 (20.0)18 (64.3)0.002
Plasma Ang-2 (pg/ml, median IQR)7720 (10108.9)7128 (9232.5)0.454
Plasma Ang-2 > 18,405 pg/ml (n, %)5 (20.0)5 (17.9)1.00
ELF Ang-2 (pg/ml, median IQR)<4 (<4)1068.2 (2349.0)0.001
ELF Ang-2 > 705 pg/ml (n, %)2 (8.0)15 (53.6)<0.0001
Plasma endocan (ng/ml, median IQR)6.15 (9.45)8.17 (15.45)0.129
Plasma endocan > 13 ng/ml (n, %)4 (16.0)10 (35.7)0.094
ELF endocan (ng/ml, median IQR)<0.31<0.311.00
Plasma PAI-I (mg/dl), median IQR)59.0 (71.4)95.0 (57.2)0.332
Plasma PAI-I > 140 mg/dl (n, %)4 (16.0)6 (21.4)0.732
Plasma protein C (mg/dl, median IQR)66.2 (42.5)45.3 (41.65)0.062
Plasma protein C < 41.5 mg/dl (n, %)4 (16.0)11 (39.3)0.074